Can I Switch Mounjaro Providers? A UK Guide to Changing Mounjaro Supplier Safely

If you are already taking Mounjaro and are thinking about moving to a different provider, the short answer is yes. You are not tied to the pharmacy or clinic that first prescribed it. You can choose to use a different provider if you prefer.

What can be confusing is that switching Mounjaro does not work like changing your broadband provider. Mounjaro is a prescription only medicine, and you are not transferring a subscription. You are continuing a course of medical treatment.

Your new provider cannot simply take over the prescription from your old provider. They need to carry out their own clinical assessment, decide whether Mounjaro is suitable for you, and issue their own prescription before the medicine can be supplied.

This extra step is there to support patient safety. In the UK, requirements for online prescribing of weight management medicines have become stricter. Knowing what the new provider may ask for can help you switch with fewer delays and avoid an unexpected gap in treatment.

Key things to know

• You can change your Mounjaro supplier if you choose to. You do not normally need permission from your previous provider.
• A prescription issued by one provider does not automatically transfer to another provider. You will normally need a new consultation and a new prescribing decision.
• Since 2025, online providers supplying weight management medicines have faced stricter requirements around independently checking information such as height, weight and BMI.
• You may need to provide your current Mounjaro strength, how long you have been taking it, the date of your last injection and any side effects you have experienced.
• Continuing at the same strength may be appropriate, but this is a clinical decision made by the new prescriber. It is not an automatic transfer.
• Start the switching process before your current supply runs out. A long gap in treatment may affect what your new prescriber recommends.
• When comparing prices, look at the standard price of the strength you are likely to need later in your treatment, rather than focusing only on the first order price.

Can You Switch Mounjaro Providers in the UK?

Yes. If you are using Mounjaro through a private UK provider, you can choose to move to a different provider during your treatment.

You do not normally need permission from the provider you are leaving. However, your new provider must make its own clinical assessment before prescribing Mounjaro.

Private weight management services may offer monthly plans or bundles, but this does not mean you are medically tied to that provider. Each supply of Mounjaro requires an appropriate prescribing decision based on your circumstances.

What you cannot assume is that your old provider can simply hand your treatment over to the new one. Private online providers may use different prescribing and pharmacy systems, and there may not be an automatic handover of your clinical information.

This is why it can help to keep a record of your own treatment. Before switching, make a note of your current dose, when you started treatment, the date of your last injection, any side effects, and any other medicines you take.

Why Transferring a Mounjaro Prescription Is Not How It Usually Works

Searches such as transfer Mounjaro prescription and transferring Mounjaro prescription to another provider suggest that many people expect a formal transfer process. In most cases, switching is better understood as starting a new prescribing relationship.

What a private prescription is, and where it can be dispensed

A private prescription is issued by an authorised prescriber. Unlike an NHS prescription, which is sent through the NHS prescription system to a nominated pharmacy, a private prescription can generally be dispensed by a pharmacy that is willing and legally able to supply it.

However, many online weight management services have the prescriber and pharmacy working within the same service. The prescription may therefore be generated and dispensed within that provider's system rather than being given to you as a separate document.

This means that having a prescription from one provider does not necessarily mean that another online provider can simply continue it.

Why the new provider issues a new prescription

A new prescriber is responsible for their own prescribing decision. They cannot simply rely on another prescriber's previous decision without carrying out an appropriate assessment.

The new provider will usually review your treatment history, current Mounjaro dose, weight and BMI, medical history, other medicines and any side effects or concerns you have experienced.

They may also need to confirm information such as your height and weight before deciding whether Mounjaro remains suitable for you.

If continuing at your current dose is clinically appropriate, the new prescriber may recommend the same strength. However, they may also recommend a different approach if your circumstances have changed or if there are concerns about your treatment.

A proper clinical review can help the new provider understand where you are in your treatment and provide appropriate advice about your next dose. It also gives you an opportunity to discuss side effects, progress or any concerns you may have before continuing treatment.

Be cautious of any service that appears willing to prescribe Mounjaro without carrying out an appropriate clinical assessment. A proper consultation is an important part of safe prescribing.

Why People Change Mounjaro Supplier

Switching supplier is common with prescription weight loss medications, and there can be many reasons for doing it. You do not normally need to justify your decision to your previous provider.

Price is often an important reason for switching, but it is worth looking at the whole service. A lower price may not be the best option if you cannot get the clinical support you need.

Before moving, compare the total cost of treatment, how prescriptions are handled, delivery arrangements and the level of clinical support available.

What a New Provider Must Check Before Prescribing Mounjaro

This is the part of switching that can surprise people. Online prescribing requirements for weight management medicines have become more detailed, so a new provider may ask for more information than your previous provider did.

Independent verification of height, weight and BMI

The General Pharmaceutical Council has strengthened its expectations around online prescribing of weight management medicines. Weight management medicines are treated as high risk medicines in the relevant pharmacy regulatory framework, and providers are expected to take steps to independently verify important information supplied by patients rather than relying only on an online questionnaire.

Depending on the service and your circumstances, this may involve timely two way communication, checking clinical records, or contacting your GP, regular prescriber or another healthcare provider.

The practical result for someone switching provider is that the new service may ask for a recent weight measurement, a photograph or video consultation, access to relevant clinical information, or permission to contact another healthcare professional.

Being asked to provide more information does not necessarily mean the provider is being difficult. It can be part of the checks needed to make a safe and appropriate prescribing decision.

Transparency about who is prescribing

The GPhC also expects pharmacy websites that provide prescribing services to give patients clear information about the service and the healthcare professionals involved.

This can include information about who is prescribing, where the prescribing service is based, whether the prescriber is a doctor or another type of authorised prescriber, and how you can check their professional registration.

Before switching provider, take a few minutes to check this information. A reputable service should make it reasonably clear who is responsible for your prescribing and how you can contact the service if you have questions.

Why the questionnaire may feel longer than last time

In April 2026, the GPhC published an analysis of inspections of online pharmacies prescribing GLP 1 medicines. It identified concerns including prescribing to people who did not meet eligibility requirements, inadequate clinical assessment and supplies being made without appropriate prescriber interaction.

The analysis also highlighted concerns about online models where there was no planned clinical review, meaning changes in a patient's health, side effects or response to treatment could potentially go unnoticed.

This means your new provider may ask more questions than your previous one. A longer consultation can be a normal part of the clinical checks required before prescribing.

If your previous provider completed your consultation very quickly and your new provider asks for more information, that does not automatically mean the new service is inefficient. It may simply be carrying out a more detailed assessment before making its prescribing decision.

Switching Mounjaro Providers Mid Dose

Changing your Mounjaro provider while you are already taking treatment can be straightforward, but your new provider still needs to assess you before deciding what to prescribe.

If you are part way through dose increases, tell the new provider exactly which strengths you have used and when you took your most recent dose. This helps the prescriber understand where you are in your treatment.

Do not assume that you should automatically move to the next strength just because you have changed provider. Mounjaro doses are increased based on individual circumstances, and dose changes should follow the prescribing information and your prescriber's advice.

It is also a good idea to start the switching process before your current pen runs out. This gives your new provider time to complete its checks and make a prescribing decision, which may help reduce the chance of an unplanned break in treatment.

What Your New Provider Needs From You

Before starting your online consultation with a new private provider, have the following information ready:

• The exact Mounjaro strength you are currently prescribed, in milligrams
• The date of your most recent weekly injection and when your next dose is due
• How long you have been on your current strength and which previous strengths you have used
• Any side effects you have experienced, including when they happened and how severe they were
• Your current weight and height, plus your weight when you started treatment
• Details of any other medicines, supplements or contraceptives you are taking
• Any changes in your health since your last assessment
• The name of your previous provider, in case your new prescriber needs to verify some of your treatment history

Keep old dispensing labels, prescription information or order confirmations where available. These can help support the information you provide about your previous treatment.

Providing accurate and complete information gives your new prescriber a clearer picture of your treatment history and helps them make an informed prescribing decision.

Can You Continue on the Same Dose?

Often, yes. If you are already established on a particular Mounjaro strength, your new prescriber may decide that continuing at the same strength is appropriate after reviewing your treatment history and current health.

However, this is not an automatic transfer or something a provider should guarantee before your assessment. Your prescriber may consider:

• How long you have been taking your current strength
• The date of your last injection and whether there has been a gap in treatment
• Your treatment progress and any side effects
• Any changes in your health or weight related conditions
• Whether your previous treatment history can be verified

If there has been a significant gap in treatment, your prescriber may recommend a lower strength or another approach before continuing. This can depend on how long you have been without treatment and your individual circumstances.

Mounjaro is prescribed using a stepwise dosing schedule. For adults, treatment starts at 2.5 mg once a week for 4 weeks, followed by 5 mg once a week. If appropriate, the dose can then be increased in 2.5 mg steps, with at least 4 weeks at each dose. The maximum dose is 15 mg once a week.

Important: Do not change your dose yourself, take extra doses to make up for a missed dose, or try to split the contents of a pen. A Mounjaro KwikPen contains 4 fixed doses and is designed to provide one dose each week.

How to Switch Mounjaro Providers Step by Step

The assessment stage cannot simply be skipped because you choose an express service. If a provider offers a faster review, it may reduce waiting time before your consultation, but the necessary clinical checks still need to be completed.

Be cautious of any service that suggests paying more will guarantee approval or bypass the usual clinical assessment.

Timing Your Switch to Avoid Running Out

It is sensible to start the switching process before your current supply runs out. This gives your new provider time to complete its assessment and make a prescribing decision.

You can help avoid unnecessary delays by:

• Starting the new consultation while you still have enough medication for your next scheduled doses
• Allowing time for clinical assessment and any follow up questions
• Checking delivery times, particularly around weekends and bank holidays
• Checking how the provider handles delivery of medicines that need specific storage conditions
• Making sure someone will be available to receive the delivery where necessary

If you miss a Mounjaro dose, do not double dose to make up for it. The UK patient information says that if the dose is 4 days or less overdue, it should be taken as soon as possible. If more than 4 days have passed, the missed dose should be skipped and the next dose taken on the usual day. There should be at least 3 days between two doses.

Checking a New Provider's Credentials

• Check that you can identify the prescriber and verify their professional registration
• Find out whether the prescriber is a doctor or another type of authorised prescriber
• Look for a clear UK address, complaints procedure and accessible customer support
• Check that the provider explains how your clinical information is assessed and who is responsible for prescribing

The GPhC has highlighted the importance of independent verification of information such as height, weight and BMI when supplying weight management medicines. Its 2026 review also identified concerns around inadequate clinical assessment and follow up.

Transparent Pricing Structure

• Look for clear pricing that explains the cost of the medicine, consultation, delivery and any additional items
• Check whether there are repeat order prices, subscription charges or other ongoing costs
• Compare the standard price of the strength you expect to need later, rather than looking only at an introductory offer
• Check what happens to the price if your dose changes

A lower first order price can look attractive, but the ongoing cost is usually more useful when comparing providers.

Clinical Support and Ongoing Care

• Check whether the provider offers follow up reviews and support during treatment
• Find out how you can contact the clinical team if you develop side effects or have questions
• Check that automated systems are used to support the service rather than replace appropriate clinical decision making
• Look for clear information about what happens if your health changes or Mounjaro is no longer considered suitable

Reviews can be useful when comparing customer service, but they should not be your only way of judging the quality of a medical service.

Important Considerations When Switching

• Switching providers can be straightforward, but your new provider still needs to carry out its own clinical assessment before prescribing.
• Your new prescriber may review your treatment history, current dose, health information, weight and BMI before deciding whether and how to continue treatment.
• Online consultations can make private weight management services convenient, but the consultation still needs to provide appropriate clinical assessment and oversight.
• Check how the provider handles delivery and storage requirements for Mounjaro, as the medicine needs to be stored according to its product information.
• Compare the full ongoing cost of treatment, not just the first order price.
• If you are switching from Mounjaro to another weight loss medicine, such as Wegovy, tell your new prescriber. They can assess your treatment history and decide how any change should be managed.
• Do not take Mounjaro and another weight loss injection together unless a healthcare professional has specifically advised you to do so.
• Tell your new prescriber about any changes in your health, medicines, side effects or treatment history so they have the information needed to make an appropriate prescribing decision.

Switching providers does not have to be complicated. The most useful thing you can do is prepare your treatment information, choose a provider with a clear clinical process, and give the new prescriber enough information to assess your situation properly.

Timing Your Switch So You Do Not Run Out

One of the most common problems when changing Mounjaro supplier is leaving the switch until the last dose is due.

A Mounjaro KwikPen contains four weekly doses. Once you have used the fourth dose, you will need a new supply for your next scheduled injection. Starting the process earlier gives your new provider time to complete its checks and make a prescribing decision.

A sensible plan is to:

• Begin your new consultation with at least two to three weeks of medicine still available
• Allow working days, rather than just a few hours, for the assessment and any follow up questions
• Allow extra time for dispensing and delivery
• Build in extra time around weekends and bank holidays, when delivery schedules can vary
• Check delivery arrangements for the Highlands, Islands and offshore postcodes, as next day delivery may not be available in all areas

If you do end up with a gap in treatment, do not try to make up for it yourself. Contact your prescriber or pharmacist for advice.

Tirzepatide is not considered addictive and missing doses is not expected to cause a physical withdrawal syndrome. However, the effects of the medicine can wear off over time after treatment stops, and your appetite may change. Weight regain can also happen after stopping weight management medicines, so speak to your healthcare professional if your treatment is interrupted or you are considering stopping.

What to Check Before You Commit to a New Mounjaro Provider

Choosing a new provider based only on price can mean you overlook other important parts of the service. Before switching, take a few minutes to check how the provider handles prescribing, clinical support, pricing and delivery.

Registration and Prescriber Transparency

• Is the pharmacy registered with the GPhC, and does the registration match the business information on the website?
• Are the prescribers clearly named, with professional registration details that you can check independently?
• Is it clear whether the prescribers are doctors, pharmacist independent prescribers or another type of authorised prescriber?
• Is there a clear UK address, complaints procedure and way to contact the service if you need help?

Both doctors and pharmacist independent prescribers can prescribe within their professional scope. The important point is that the provider should make it clear who is responsible for your prescribing.

Total Cost, Not Just the Headline Price

The price shown for a first order may not reflect what you will pay over the longer term.

When comparing providers:

• Check the standard price rather than focusing only on a first order discount
• Compare the strength you expect to use later in treatment, rather than only the starting strength
• Add delivery costs and check whether faster delivery costs extra
• Check whether there are consultation or express review fees
• Check whether pen needles and a sharps bin are included or need to be purchased separately
• If you are comparing a full year of treatment, remember that 52 weeks is equivalent to 13 four dose pens, although your actual treatment may involve different strengths and periods between doses

Looking at the full ongoing cost gives you a more realistic comparison than focusing on the cheapest introductory offer.

Ongoing Review and Support

A good provider should make it clear what clinical support is available during treatment.

Before switching, ask:

• Will your treatment be reviewed regularly, or is a new supply mainly based on you placing another order?
• How can you contact a prescriber if you develop side effects or have questions between orders?
• What happens if you need to pause treatment or your health changes?
• How does the provider review whether continuing Mounjaro remains appropriate for you?

Clear answers to these questions can help you understand what to expect after your first order.

Red Flags When Comparing Providers

Be cautious if a provider:

• Offers Mounjaro without an appropriate clinical assessment
• Claims that your existing prescription can simply be taken over without a new prescribing assessment
• Guarantees approval or a particular strength before reviewing your medical information
• Claims to have a permanent supply of every strength, as pharmacy stock can change
• Uses strong pressure tactics or countdown offers around a prescription only medicine
• Offers products in formats that do not match the authorised UK product, such as unlicensed vials or tablets, without clearly explaining their regulatory status

Mounjaro is supplied in the UK as a prescription only injectable medicine containing tirzepatide. Be particularly careful with products sold online as unbranded or unauthorised versions of Mounjaro.

The MHRA issued an alert in February 2026 about falsified Mounjaro pens labelled as 15 mg. One reported feature was a dose knob that detached from the pen. If a pen you receive looks unusual, damaged or different from what you expect, do not use it. Contact the dispensing pharmacy for advice and consider reporting a suspected medicine problem through the MHRA Yellow Card scheme.

Mounjaro Prices and What They Mean Over a Year

The prices below are standard single pen prices for Mounjaro treatment at EverydayMeds, correct at the time of writing. The live pricing table on the product page always takes precedence, and all treatment is subject to a prescriber consultation and clinical approval.

The annual column is illustrative rather than a prediction of how your treatment will progress. Most people do not stay on one Mounjaro strength for an entire year. The purpose of the calculation is to show how the strength you use can affect the overall cost.

The step from 10 mg to 12.5 mg is the largest single increase in this price range, at £30.00 per pen.

This is why comparing providers using only the price of a starter pen can be misleading. If you are switching while taking 10 mg, for example, compare the standard 10 mg price at both providers, along with delivery, consultation and any other ongoing costs.

Changing Provider Is Not the Same as Changing Medicine

Changing provider means continuing with the same medicine through a different prescribing and dispensing service. Changing medicine, such as moving from a semaglutide injection to Mounjaro, is different because it involves a different active ingredient and treatment approach.

You should not switch between weight management medicines on your own. Their strengths are not directly interchangeable, and the appropriate dose depends on the medicine and your individual circumstances.

If you are considering changing from Mounjaro to another weight management medicine, tell your new prescriber exactly what you have been taking, including the strength and date of your last dose. Your prescriber can then assess the change and decide how treatment should be managed.

It is worth reading about the available weight loss treatments before you make a decision.

Storage and Delivery When Your Supply Moves

Changing provider also means using a different dispensing and delivery service. Mounjaro needs to be stored correctly to maintain the quality of the medicine.

• Unused pens should be stored in a refrigerator between 2°C and 8°C
• Do not freeze Mounjaro. If a pen has been frozen, do not use it
• Keep the pen in its original carton to protect it from light
• After first use, a Mounjaro KwikPen can be stored below 30°C for up to 30 days, in line with the product information
• The solution should be clear and colourless to slightly yellow

If a delivery arrives late, appears damaged or has been exposed to unsuitable temperatures, contact the dispensing pharmacy before using the pen. Keep the packaging until you have received advice.

Remember that the Mounjaro injection KwikPen is supplied without needles. If your previous provider included compatible pen needles and your new provider does not, you may need to obtain them separately. You will also need an appropriate sharps bin for used needles.

Switching Back, or Leaving Again

You are not locked into your new provider either. If you decide to move again, the same basic process applies.

Keep your own treatment record as you go. Note the strengths you have used, when you started and finished each strength, the dates of your injections and any side effects you experienced.

Having a clear treatment history can make future consultations easier because your new prescriber has useful information to review.

Common Mistakes When Changing Mounjaro Supplier

• Leaving the switch until your last dose and then feeling pressured to choose the first provider that responds
• Leaving out side effects or previous doses because you are worried they could affect the prescribing decision
• Assuming approval is automatic because another provider prescribed Mounjaro previously
• Choosing a provider based only on the first order price and then discovering that ongoing prices are higher
• Buying a multi pen bundle before your new prescriber has confirmed the appropriate treatment plan
• Stretching an existing pen or changing the dose yourself to cover a delay
• Buying Mounjaro from an unregistered or unreliable source to fill a gap in treatment

Medical Disclaimer

This article provides general information about the practical and regulatory aspects of changing Mounjaro provider in the United Kingdom. It is not medical advice, a clinical recommendation or a substitute for an individual assessment by a qualified prescriber.

Mounjaro is a prescription only medicine. It should only be used under the supervision of an appropriately qualified UK prescriber. Whether it is suitable for you depends on your individual health, medical history and other circumstances.

Nothing in this article should be taken as advice to start, stop, continue, pause or change the strength of any medicine you are taking. Do not change your Mounjaro dose without speaking to your prescriber.

Results can vary between individuals, and results reported in clinical studies are population averages rather than a prediction of what one person will experience.

If you experience side effects or have concerns about your treatment, contact your prescriber or GP. NHS 111 can also provide advice when appropriate. Suspected side effects can be reported through the MHRA Yellow Card scheme. In a medical emergency, call 999.